Dr. Salil Goorha, MD

Dr. Goorha practices at Baptist Memorial Hospital-Tipton in Covington, Tennessee, part of Baptist Memorial Health Care.

Dr. Goorha's NPI, 1124241062, was assigned on April 10, 2007. Dr. Goorha graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2000. Dr. Goorha's Tennessee license number on file is 38210.

Dr. Goorha's primary practice is Baptist Memorial Hospital-Tipton, at 1995 Highway 51 S, Covington, TN 38019 in Tipton County. The practice phone is (901) 476-2621.

Dr. Goorha's primary practice is Baptist Memorial Hospital-Tipton in Covington, Tennessee, part of Baptist Memorial Health Care. Dr. Goorha is also affiliated with Baptist Memorial Hospital-Memphis. The medical group on file is Baptist Medical Group. Dmand AI also links Dr. Goorha to 1 more hospital, 5 medical groups, 3 group practices and clinics and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goorha practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Goorha's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Goorha is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Goorha's licenses on file in 5 states: Tennessee, Alaska, Mississippi, Arkansas and Utah.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), immune deficiency disease, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Goorha treats.

CMS data shows 1,750 Medicare services from Dr. Goorha across 10 procedure codes in 2024, for 213 Medicare patients. Medicare paid $102,568 for them.

CMS counts 213 Medicare patients who saw Dr. Goorha in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goorha's median patient age at 71, with 50% women.

In 2024, Dr. Goorha wrote 1,712 Medicare Part D claims for 141 patients. 70% of them were for generic drugs. CMS names the drug for 1,367 of them, across 46 drugs with 11 or more claims each, at $3,667,916 in total drug cost. In 2023, CMS named 1,106 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Goorha for performance year 2024, reported as part of a group. Dr. Goorha accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Goorha, published from 2006 to 2022. 2012 was the busiest year, with 3. The most frequent topics are Leukemia, Myeloid, Acute, Antineoplastic Agents and Body Mass Index. Dr. Goorha has published most often in J Natl Compr Canc Netw. Dr. Goorha's most frequent co-authors are Lloyd Damon, MD, Jeffrey E. Rubnitz, MD and Jessica Kaplan Altman, MD.

Dmand AI links Dr. Goorha to 7 clinical trials. 4 are still active or recruiting. Conditions studied include Leukemia, Promyelocytic, Acute, Cytopenia and GATA2 Deficiency. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 1,045 general payments to Dr. Goorha from 76 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 38% of the total. Seagen Inc. paid the most, $17,367.

Dmand AI lists 1 award for Dr. Goorha, most recently Young Investigator Award in 2010.

Dr. Goorha graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2000.

Dr. Goorha is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.